Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

201 trials with published results (24%)

Research Maturity

495 completed trials (58% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.9%

42 terminated out of 853 trials

Success Rate

92.2%

+5.7% vs benchmark

Late-Stage Pipeline

26%

226 trials in Phase 3/4

Results Transparency

41%

201 of 495 completed with results

Key Signals

201 with results92% success42 terminated

Data Visualizations

Phase Distribution

668Total
Not Applicable (303)
Early P 1 (4)
P 1 (56)
P 2 (79)
P 3 (129)
P 4 (97)

Trial Status

Completed495
Unknown99
Recruiting97
Terminated42
Not Yet Recruiting38
Active Not Recruiting31

Trial Success Rate

92.2%

Benchmark: 86.5%

Based on 495 completed trials

Clinical Trials (853)

Showing 20 of 20 trials
NCT05156398Phase 3RecruitingPrimary

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

NCT06323928Phase 2Active Not RecruitingPrimary

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

NCT06788977Recruiting

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

NCT05164172Phase 3RecruitingPrimary

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

NCT00071786Completed

Family Study of Affective and Anxiety Spectrum Disorders

NCT06241313Phase 3RecruitingPrimary

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06735833Not ApplicableRecruitingPrimary

MMA Embolization for Refractory Chronic Migraine

NCT07071506Not ApplicableRecruitingPrimary

New Methods for Evaluating Preventive Migraine Treatment

NCT06616194Phase 3RecruitingPrimary

A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

NCT06200480Not ApplicableTerminatedPrimary

Nurse Intervention Trial

NCT07519343Not Yet RecruitingPrimary

Migraine and Endometriosis: The FEMININE Study

NCT07035197CompletedPrimary

Facilitators and Barriers to Eptinezumab Administration in Thailand

NCT04567355Phase 2Active Not RecruitingPrimary

Migraine Manager (R01)

NCT04252742Phase 4CompletedPrimary

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

NCT05003362Not ApplicableCompletedPrimary

ACT for High Frequency Migraine; A Virtual Mindfulness Intervention

NCT07493434Not ApplicableEnrolling By InvitationPrimary

Evaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial

NCT07487701Not ApplicableActive Not RecruitingPrimary

Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study

NCT07479212Not Yet Recruiting

Headache Prevalence and Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody -Associated Disease (MOGAD)

NCT04715685Not ApplicableRecruiting

Mind Body Balance for Pediatric Migraine

NCT07100496Phase 4Active Not RecruitingPrimary

Evaluation of MIG-SPRAY Treatment on Migraine

Scroll to load more

Research Network

Activity Timeline